Evidence map›Paper›PMID 41934675›Full record

ArticleEuropean journal of public health2026

Spatial resolution of exposure to particulate matter (PM2.5) and the impact on the burden of disease in Germany.

Stefan Wallek, Marcel Langner, Dietrich Plass, Sarah Kienzler, Tobias Sauter

Erratum issuedAbstract read
In one paragraph

Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Stefan WallekGerman Environment Agency, Dessau-Roßlau, Germany.ORCID 0000-0001-8821-0229
Marcel LangnerGerman Environment Agency, Dessau-Roßlau, Germany.
Dietrich PlassGerman Environment Agency, Dessau-Roßlau, Germany.
Sarah KienzlerGerman Environment Agency, Dessau-Roßlau, Germany.
Tobias SauterGeography Department, Faculty of Mathematics and Natural Sciences, Humboldt-Universität zu Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate estimation of the disease burden attributable to ambient particulate matter (PM2.5) requires reliable exposure data with an adequate spatial resolution. While coarse-resolution models are commonly used for national assessments, the impact of spatial resolution on environmental burden of disease (EBD) estimates remains understudied. We compared two modelling approaches for PM2.5 exposure in Germany: a chemical transport model (REM-CALGRID [RCG], 2 × 2 km² resolution) and a high-resolution hybrid geostatistical land-use regression model (PMR, 100 × 100 m² resolution). EBD estimates were calculated for five health outcomes using established concentration-response functions. Across all outcomes, the PMR model consistently produced slightly higher EBD estimates-approximately 2%-3% higher disability-adjusted life years (DALYs) than the coarser RCG model. The difference is due to improved detection of local pollution hotspots and more accurate exposure assignments in the high-resolution model. A larger share of the population was classified into higher exposure categories under the PMR model. Although the added value of high-resolution modelling is limited at national level, it offers clear benefits for small-area analyses and applications in environmental justice and health equity. Our findings support the integration of fine-scale exposure data into public health surveillance and burden of disease (BoD) assessments where feasible.

Indexed as

Air PollutantsAir PollutionCost of IllnessEnvironmental ExposureParticulate MatterDisability-Adjusted Life YearsEnvironmental MonitoringGermanyHumansAir PollutantsParticulate Matter

Identifiers

PMID41934675
PMCPMC13050263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.